Loading clinical trials...
Loading clinical trials...
Cocaine potently inhibits the reuptake of serotonin (5-HT). Increased synaptic 5-HT resulting from this reuptake inhibition activates multiple 5-HT receptor subtypes. Some of these receptor subtypes h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
William Stoops
Collaborators
NCT07227948 · Cocaine Use Disorder
NCT07071779 · Alcohol Use Disorder (AUD), Cocaine Use Disorder (CUD), and more
NCT04927143 · Opioid-use Disorder, Cocaine Use Disorder, and more
NCT04721418 · Cocaine Use Disorder, Healthy Controls
NCT05011760 · Cocaine Use Disorder
University of Kentucky
Lexington, Kentucky
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions